Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Before getting a cash advance, it's crucial to know the key factors involved. We provide insights to help you make informed decisions.
22,697 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
A chief revenue officer at a growing restaurant-tech company recently sold a sizable block of stock. Insider moves li...
Tempo, the stripe-backed crypto startup, launches a cross-chain AI payments protocol and goes live with its Tempo blo...
The one-time $255 death benefit from Social Security hasn’t kept pace with rising funeral costs. This report explains...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
Oil’s 5.7% weekly drop is fueling a rotation into jet, materials, and infrastructure plays as traders reassess fuel c...
January payrolls rose 130,000 with the jobless rate at 4.3%, while revisions to prior months add uncertainty as trade...
CFOs face a pivotal call as Microsoft’s 2026 Work Trend Index links AI ROI to organizational design, not merely softw...
Healthcare investing comes in two main flavors: a market-weighted healthcare active manager approach and a more passi...
When markets plunge, the question isn’t just about losses. Could buying Ethereum during a crypto crash turn into mean...
The Senate Banking Committee unveiled a sweeping 309-page crypto bill early Tuesday, aiming to overhaul market struct...
AllUnity launches SEKAU, the first MiCA-aligned SEK stablecoin, testing Europe’s switch to local-currency settlement ...